The global stress management market is anticipated to increase by USD 5 billion till 2028 at an average annual growth of 3.8 percent as per the latest report by Gen Consulting Company.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, age group, end user, and region. The global market data on stress management can be segmented by product: medications, devices. The medications segment held the largest revenue share in 2021. Stress management market is further segmented by age group: adults, children, elderly. Among these, the adults segment was accounted for the highest revenue generator in 2021. Based on end user, the stress management market is segmented into: ambulatory surgical centers, hospitals and clinics, others. The hospitals and clinics segment captured the largest share of the market in 2021. On the basis of region, the stress management market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). According to the research, Europe had the largest share in the global stress management market.
The global stress management market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Abbott Laboratories, Allergan plc, Apple Inc., AstraZeneca plc, Bausch Health Companies Inc., Bristol Myers Squibb (BMS), Eli Lilly and Company, F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Lupin Limited, Merck & Co., Mylan N.V., Pfizer Inc., Samsung Electronics Co. Ltd., Takeda Pharmaceutical Co. Ltd.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
– Get a detailed picture of the Global Stress Management Market
– Identify segments/areas to invest in over the forecast period in the Global Stress Management Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 3.8% |
| Pages | 24 |
| Key Players | Abbott Laboratories, Allergan plc, Apple Inc., AstraZeneca plc, Bausch Health Companies Inc., Bristol Myers Squibb (BMS), Eli Lilly and Company, F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Lupin Limited, Merck & Co., Mylan N.V., Pfizer Inc., Samsung Electronics Co. Ltd., Takeda Pharmaceutical Co. Ltd. |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
